{"nctId":"NCT01638416","briefTitle":"Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial","startDateStruct":{"date":"2012-10"},"conditions":["Transfusion","Age of Blood"],"count":4994,"armGroups":[{"label":"Standard of care","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Blood transfusion"]},{"label":"Arm B","type":"OTHER","interventionNames":["Other: Blood transfusion"]}],"interventions":[{"name":"Blood transfusion","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients hospitalised in ICU with an anticipated ICU stay of at least 24 hours, in whom the decision has been made by medical staff to transfuse at least one RBC unit.\n\nExclusion Criteria:\n\n* Age younger than 18\n* Previous RBC transfusion during the current hospital admission (including transfusion in another hospital for transferred patients)\n* Diagnosis of transplantation or hematologic diseases\n* Pregnancy\n* Cardiac surgery during the present hospital admission\n* Expected to die imminently (\\<24hrs)\n* The treating physician believes it is not in the best interest of the patient to be randomised in this trial.\n* Known objection to the administration of human blood products\n* Participation in a competing study (see below)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mortality at Day 90","description":"Mortality at Day 90","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"610","spread":null},{"groupId":"OG001","value":"594","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"264","spread":null},{"groupId":"OG001","value":"259","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"346","spread":null},{"groupId":"OG001","value":"335","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"152","spread":null},{"groupId":"OG001","value":"169","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"457","spread":null},{"groupId":"OG001","value":"425","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"210","spread":null},{"groupId":"OG001","value":"191","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"400","spread":null},{"groupId":"OG001","value":"403","spread":null}]}]}]},{"type":"SECONDARY","title":"Mortality at Day 28","description":"Mortality at day 28","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"476","spread":null},{"groupId":"OG001","value":"463","spread":null}]}]}]},{"type":"SECONDARY","title":"Persistent Organ Dysfunction Combined With Death Measured at Day 28","description":"Persistent Organ Dysfunction combined with death measured at day 28","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"573","spread":null},{"groupId":"OG001","value":"549","spread":null}]}]}]},{"type":"SECONDARY","title":"Days Alive and Free of Mechanical Ventilation","description":"Days alive and free of mechanical ventilation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Day Alive and Free of Renal Replacement Therapy.","description":"Day alive and free of renal replacement therapy.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"22","spread":null}]}]}]},{"type":"SECONDARY","title":"Blood Stream Infection in ICU (Post Randomisation)","description":"Blood stream infection in ICU (post randomisation) Time Frame is in Days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"123","spread":null},{"groupId":"OG001","value":"88","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Stay in ICU and in Hospital Post Randomisation (Days)","description":"Median duration in ICU - short term storage group was 4.2 (2.0 - 9.3), long term storage group was 4.2 (1.9 - 9.4) Median duration in Hospital - short term storage group was 14.5 (7.4 - 27.5), long term storage group was 14.7 (7.4 - 28.3) In Days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":null},{"groupId":"OG001","value":"4.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.5","spread":null},{"groupId":"OG001","value":"14.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Patients Who Suffer at Least One Febrile Non-haemolytic Transfusion Reaction in ICU","description":"Proportion of patients who suffer at least one febrile non-haemolytic transfusion reaction in ICU","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"39","spread":null}]}]}]},{"type":"SECONDARY","title":"EuroQol-5Dimension 5 Level (EQ-5D-5L) Score at Day 180 Post Randomisation","description":"EuroQol-5Dimension 5 level (EQ-5D-5L) score at day 180 post randomisation - not reported yet","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":2457},"commonTop":["New Bloodstream Infection in ICU","Febrile Nonhaemolytic transfusion reaction"]}}}